Taking antibodies to the next dimension

The GEM-DIMER™ Platform:

A revolutionary class of therapeutics

Uniquely enables (i) cooperative binding to disease targets allowing for orders-of-magnitude enhanced activity and (ii) greater degrees of multivalency and multispecificity than possible with conventional approaches, to produce molecules with entirely new functionality for superior safety and efficacy +


Hinge Bio is led by a highly experienced team that has delivered numerous platform and drug development successes +

Hinge Bio is looking for talent with the passion and commitment to bring the next generation of therapeutics to patient care +